Disparities in NIH funding for epilepsy research
- 27 September 2011
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 77 (13) , 1305-1307
Abstract
Using data from NIH Research Portfolio Online Reporting Tools (RePORT) and recently assembled prevalence estimates of 6 major neurologic diseases, we compared the relative prevalences and the annual NIH support levels for 6 major neurologic disorders: Alzheimer disease, amyotrophic lateral sclerosis (ALS), epilepsy, multiple sclerosis, Parkinson disease, and stroke. Compared to these other major neurologic disorders, epilepsy research is funded at a persistently lower rate based on relative disease prevalences. Relative NIH funding for these other disorders in 2010 adjusted for prevalence ranged from 1.7x (stroke) to 61.1x (ALS) greater than epilepsy. The disparity cannot be explained by differences in the overall impact of these diseases on US citizens. Greater transparency in the review and funding process is needed to disclose the reason for this disparity.Keywords
This publication has 11 references indexed in Scilit:
- The social and economic consequences of epilepsy: A controlled national studyEpilepsia, 2011
- Long-Term Mortality in Childhood-Onset EpilepsyNew England Journal of Medicine, 2010
- Temporal trends in the mortality of people with epilepsy: A reviewEpilepsia, 2010
- Cognitive consequences of childhood-onset temporal lobe epilepsy across the adult lifespanNeurology, 2010
- Suicide and epilepsyCurrent Opinion in Neurology, 2009
- Quality-of-life trajectories in epilepsy: A review of the literatureEpilepsy & Behavior, 2008
- Chapter 20 Psychiatric Comorbidities in Epilepsy2008
- How common are the “common” neurologic disorders?Neurology, 2007
- Cognitive prognosis in chronic temporal lobe epilepsyAnnals of Neurology, 2006
- Patients' Experiences of Injury as a Result of EpilepsyEpilepsia, 1997